Anzeige
Mehr »
Mittwoch, 08.10.2025 - Börsentäglich über 12.000 News
Defence-Aktie mit Ritterschlag: Regierungs-Einladung zur größten Militärmesse
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
15:47Ex-FDA chief Peter Marks joins Eli Lilly's infectious disease unit
13:37MapLight's $251m IPO sees schizophrenia drug developers on top
13:37Affinia raises $40m for gene therapy development
13:37Oragenics partners Receptor.AI for brain health candidate portfolio
13:37CDC amends Covid-19, chickenpox immunisation schedule amid vaccine controversy
13:37Lilly's Omvoh benefit continues for four years in UC
MoFunds dry up for mRNA vaccines amid US political storm
MoFDA backs generics onshoring push with ANDA priority scheme
MoRocket ditches blood disorder gene therapy in ongoing pipeline pivot
MoTrogenix lands $95m Series A, backed by Eli Lilly, for brain cancer therapy
MoJazz and Roche's Zepzelca-Tecentriq wins FDA ES-SCLC approval
MoMcMaster University and MIT discover new antibiotic for IBD
FrFDA approves mifepristone generic as political abortion war rages on
FrTakeda walks away from cell therapy in priority U-turn
FrAmgen's Phase III data supports FDA label expansion of Repatha
DoFDA winds down operations amid government shutdown
DoFDA leaders are "acting political", says ex-agency chief counsel
DoHalozyme eyes microparticles in $900m Elektrofi acquisition
DoAbbVie breaks ground on $70m US biologics site amid Trump pressure
01.10.US Government shuts down over funding impasse
01.10.Pfizer shakes hands with White House on drug discounts under MFN programme
01.10.Klotho to acquire Turn Biotechnologies' assets
01.10.Star Therapeutics gains $125m Series D funds to develop pipeline
01.10.Disruption due for long-held assumptions in biopharma, says BIA chair
30.09.Genmab to acquire Merus shares for $8bn